Ominous Electrocardiographic Abnormalities in a Patient With Hepatocellular Carcinoma
Authors:
- 1 June 2022
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 182 (6) , 674-675
Abstract
This case report describes the electrocardiogram findings of a patient with 1 week of progressive weakness, myalgia, dyspnea, and ptosis.Keywords
This publication has 5 references indexed in Scilit:
- Recurrent Syncope in a Patient With Bifascicular BlockJAMA Internal Medicine, 2022
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline UpdateJournal of Clinical Oncology, 2021
- Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated MyocarditisCirculation, 2020
- Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trialThe Lancet Oncology, 2020
- Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related CardiotoxicityCirculation, 2017